672 related articles for article (PubMed ID: 2733454)
1. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
2. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
3. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
4. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
Mills KI; Sproul AM; Leibowitz D; Burnett AK
Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
6. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
[TBL] [Abstract][Full Text] [Related]
8. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
9. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
10. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
[TBL] [Abstract][Full Text] [Related]
11. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
12. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.
Selleri L; Emilia G; Temperani P; Grassilli E; Zucchini P; Tagliafico E; Bonati A; Venezia L; Ferrari S; Torelli U
Leukemia; 1989 Jul; 3(7):538-42. PubMed ID: 2733455
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis.
Price CM; Foadi MD; Morgan GJ; Wiedemann LM
Leukemia; 1990 Jun; 4(6):455-7. PubMed ID: 2359347
[TBL] [Abstract][Full Text] [Related]
15. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; GodÃnez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
16. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
17. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
Mills KI; Stewart J; Burnett AK
Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
[TBL] [Abstract][Full Text] [Related]
18. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
19. CML patients in blast crisis have breakpoints localized to a specific region of the BCR.
Schaefer-Rego K; Dudek H; Popenoe D; Arlin Z; Mears JG; Bank A; Leibowitz D
Blood; 1987 Aug; 70(2):448-55. PubMed ID: 3038213
[TBL] [Abstract][Full Text] [Related]
20. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
